CHM chimeric therapeutics limited

Ann: AML patient achieves Complete Response in CHM CORE-NK trial, page-54

  1. 132 Posts.
    lightbulb Created with Sketch. 45
    Exciting announcement. My fingers are crossed similar results are achieved for the other trial participants.
    The headline pecked my interest as the old man was knocked over by AML last year, 3 weeks from diagnosis to passing away. Incredibly aggressive disease, so I think a CR is pretty amazing and hopefully works for others. Even if it gives patients an extra 6 months of good living to do the things they want to do, people with AML should be queuing up imo.
    I will follow with interest and likely purchase a few.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
30 17137000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28294475 26
View Market Depth
Last trade - 09.01am 18/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.